Elevance Health has improved its earnings per share (EPS) forecast for 2026 to at least $26.75, aiming for a growth rate of 12% in 2027, despite carrying a substantial debt of $31.84 billion. Currently trading at $389.82 after a slight dip, the company boasts a market cap of $84.65 billion and generated $200.41 billion in revenue over the past year. While its financials demonstrate resilience, Elevance continues to navigate the complexities of the healthcare market, striving to enhance health outcomes for its members.
“Elevance Health · is a health company dedicated to improving · lives and communities”
“Elevance Health · operates · CarelonRx · the smallest integrated PBM covered here”
“ELV · stock price · value · 389.82”
“Elevance Health · is trading at · current price · $389.82”
“Elevance Health · has · total debt · $31.84B”
“Elevance Health · has · cash and cash equivalents · $9.66B”
“Elevance Health · has · dividend yield · 1.76%”
“Elevance Health · has · market cap · $84.65B”
“Elevance Health · has · revenue (TTM) · $200.41B”
“Elevance Health · has · net income (TTM) · $5.24B”
“Elevance Health · has · EPS (TTM) · $23.50”
“Elevance Health · has · P/E Ratio · 16.59”